Gainers Mobiquity Technologies (NASDAQ:MOBQ) shares increased by 26.0% to $0.44 during Tuesday’s after-market session. VS Media Holdings (NASDAQ:VSME)…
Shares of SpringWorks Therapeutics, Inc. (NASDAQ: SWTX) surged in pre-market trading after the company reported the FDA approval of OGSIVEO (nirogacestat) as the first and only treatment for adults with desmoid tumors.
SpringWorks Therapeutics shares rose 14.4% to $23.77 in pre-market trading